PATENT CLAIM ANALYSIS

Application Number: 16205637
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "751000"]

Abstract:
The present invention is directed to novel compounds of Formula (I), pharmaceutically acceptable salts or solvates thereof, and their use.

Claim (Index 36):
The method according to  claim 34 , wherein the sigma-1 receptor related disease is a neurodegenerative disease.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 98.0
- Lexical Diversity: 1.04167
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15317742', '11829531', '11463825', '15109101', '11909144']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8004920115964926
- 35 USC 102 Novelty (BERT): 0.5519509815705324
- Combined Prediction Score: 0.7756379085938967
- Mean Citation Score: 334.06991000000005
- Max Citation Score: 502.98242
- Similarity Product: 253.44843009583

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test